Therapy resistance occurs due to multiple reasons. Genetic mutations within cancer cells can lead to changes in drug targets, making the drugs less effective. Additionally, cancer cells can activate alternative signaling pathways to bypass the inhibited pathway. Another reason is the tumor microenvironment, which can protect cancer cells from therapeutic agents. Furthermore, cancer stem cells, a subpopulation within the tumor, are often more resistant to treatments.
